Investors would re-rate the stock as a growth pharma company, with a P/E in the mid-teens, driving the share price north of $50
Psychophysical testing of smell and taste function
These include neurodegenerative conditions like Parkinsons and Alzheimers, as glutathione protects brain cells from oxidative damage
Novo acquired exclusive rights to develop, manufacture, and commercialize UBT-251 outside of mainland China, Hong Kong, Macau, and Taiwan
Taken orally, its a combination of two medications bupropion and naltrexone which work together to curb cravings and reduce appetite, especially when emotional eating or overeating is present
We propose regulating melanin levels may offer new avenues for treatment development